Glycosphingolipid expression in pig aorta: identification of possible target antigens for human natural antibodies.
Total non-acid glycosphingolipids were isolated from the aortas of more than 80 pigs. The glycolipids were separated by HPLC, analysed by thin-layer chromatography, and tested for reactivity with monoclonal anti-blood group antibodies. The fractions were structurally characterized by NMR spectroscopy and mass spectrometry. Reactivity with both anti-blood group A and H antibodies was seen. The major glycosphingolipid constituents were globotri- and globotetraosylceramides and blood group H pentaglycosylceramides based on type 1 and type 2 core saccharide chains. Globopentaosylceramides, blood group H hexaglycosylceramides based on type 4 chain, and blood group A hexaglycosylceramides based on type 1 core chain were also present. Two structures, that may be important targets for human antibodies initiating hyperacute rejection following pig to human xenotransplantation, were present as minor constituents compared to the blood group components. These were Galalpha1,3neolactotetraosylceramide and a Galalpha1, 3Lexstructure. A Leb/Y hexaglycosylceramide was also present.
Hallberg
E C
EC
Department of Clinical Chemistry and Transfusion Medicine, Göteborg University, S-413 45 Göteborg, Sweden.
Holgersson
J
J
Samuelsson
B E
BE
D000818:Animals; D000911:Antibodies, Monoclonal; D000936:Antigen-Antibody Complex; D001011:Aorta / Q000737:chemistry* / Q000378:metabolism; D001789:Blood Group Antigens / Q000276:immunology*; D002240:Carbohydrate Sequence; D002855:Chromatography, Thin Layer; D006017:Glycolipids / Q000737:chemistry; D006028:Glycosphingolipids / Q000096:biosynthesis* / Q000737:chemistry / Q000276:immunology*; D006801:Humans; D013058:Mass Spectrometry; D008969:Molecular Sequence Data; D019906:Nuclear Magnetic Resonance, Biomolecular; D013552:Swine
D000911:Antibodies, Monoclonal; D000936:Antigen-Antibody Complex; D001789:Blood Group Antigens; D006017:Glycolipids; D006028:Glycosphingolipids